James Conway

1.3k total citations · 1 hit paper
14 papers, 340 citations indexed

About

James Conway is a scholar working on Surgery, Molecular Biology and Immunology. According to data from OpenAlex, James Conway has authored 14 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 5 papers in Molecular Biology and 4 papers in Immunology. Recurrent topics in James Conway's work include Eosinophilic Esophagitis (2 papers), Advanced Proteomics Techniques and Applications (2 papers) and Liver Disease Diagnosis and Treatment (2 papers). James Conway is often cited by papers focused on Eosinophilic Esophagitis (2 papers), Advanced Proteomics Techniques and Applications (2 papers) and Liver Disease Diagnosis and Treatment (2 papers). James Conway collaborates with scholars based in United States, United Kingdom and Netherlands. James Conway's co-authors include Michael Kinter, Christopher J. Rhodes, Silvia Guionaud, James L. Trevaskis, Lutz Jermutus, Joseph Grimsby, Michael Feigh, Martin R. Larsen, Brandon B. Boland and Hilary Lewis and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and Diabetes.

In The Last Decade

James Conway

14 papers receiving 337 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Resolution of NASH and hepatic fibrosis by the GLP-1R and GCGR dual-agonist cotadutide via modulating mitochondrial function and lipogenesis

2020 200 citations Michelle L. Boland, Rhianna C. Laker et al. Nature Metabolism profile →

Peers

Countries citing papers authored by James Conway

Since Specialization

Citations

This map shows the geographic impact of James Conway's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Conway with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Conway more than expected).

Fields of papers citing papers by James Conway

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Conway. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Conway. The network helps show where James Conway may publish in the future.

Co-authorship network of co-authors of James Conway

This figure shows the co-authorship network connecting the top 25 collaborators of James Conway. A scholar is included among the top collaborators of James Conway based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Conway. James Conway is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Inhibition of Interleukin-33 to Reduce Glomerular Endothelial Inflammation in Diabetic Kidney Disease 2024 ·Kidney International Reports ·Alexis Hofherr, (unknown), Barbara Musiał, Asha Seth, (unknown), James Conway, David Baker, Pernille Hansen, Benjamin Challis, Stefano Bartesaghi, Maria Bhat, Roberto Pecoits‐Filho, (unknown), (unknown), Kevin Woollard, Hiddo J.L. Heerspink	6
2	Cultivation, chemistry, and genome of Psilocybe zapotecorum 2024 ·PubMed ·Dusty R. Miller, (unknown), (unknown), (unknown), (unknown), James Conway, Jason C. Slot, David E. Cliffel	3
3	#5413 FRONTIER-1: A PHASE 2B STUDY OF IL-33 BLOCKADE IN DIABETIC KIDNEY DISEASE 2023 ·Nephrology Dialysis Transplantation ·(unknown), Barbara Musiał, Asha Seth, (unknown), James Conway, David H. Baker, (unknown), Benjamin Challis, Maria Bhat, Stefano Bartesaghi, Roberto Pecoits‐Filho, (unknown), (unknown), Kevin Woollard, Hiddo J.L. Heerspink, Alexis Hofherr	1
4	Abstract CT039: Immunomodulatory effects of ceralasertib in combination with durvalumab in patients with NSCLC and progression on anti-PD-(L)1 treatment (HUDSON, NCT03334617) 2023 ·Cancer Research ·Sonia Iyer, James Conway, Deanna L. Russell, (unknown), Jan Cosaert, Simon T. Barry, (unknown), (unknown), Boaz E. Aronson, (unknown), Helen Ambrose, Keunchil Park, Patrick M. Forde, Benjamin Besse, John V. Heymach, J. Carl Barrett	2
5	Resolution of NASH and hepatic fibrosis by the GLP-1R and GCGR dual-agonist cotadutide via modulating mitochondrial function and lipogenesis breakdown → 2020 ·Nature Metabolism ·Michelle L. Boland, Rhianna C. Laker, (unknown), Arkadiusz Nawrocki, Stephanie Oldham, Brandon B. Boland, Hilary Lewis, James Conway, Jacqueline Naylor, Silvia Guionaud, Michael Feigh, Sanne Skovgård Veidal, Louise Lantier, Owen P. McGuinness, Joseph Grimsby, Cristina M. Rondinone, Lutz Jermutus, Martin R. Larsen, James L. Trevaskis, Christopher J. Rhodes	200
6	Improved Therapeutic Window in BRCA -mutant Tumors with Antibody-linked Pyrrolobenzodiazepine Dimers with and without PARP Inhibition 2018 ·Molecular Cancer Therapeutics ·Haihong Zhong, Chen Cui, Ravinder Tammali, Shannon Breen, (unknown), Christine Fazenbaker, (unknown), James Conway, Brandon W. Higgs, Nicholas Holoweckyj, Rajiv Raja, Jay Harper, Andrew J. Pierce, Ronald Herbst, David A. Tice	12
7	MEDI0382, a GLP-1/Glucagon Receptor Dual Agonist, Dramatically Reduces Hepatic Collagen in a Mouse Model of NASH 2018 ·Diabetes ·(unknown), Silvia Guionaud, James Conway, (unknown), Christopher J. Rhodes, Lutz Jermutus, James L. Trevaskis	4
8	Quantitative Proteomics in Laser Capture Microdissected Sleep Nuclei From Rat Brain 2014 ·Journal of Neurogenetics ·Ronald Miller, Christopher J. Winrow, Daniel S. Spellman, Qinghua Song, Duane R. Reiss, James Conway, (unknown), Paul J. Coleman, Ronald C. Hendrickson, John J. Renger	7
9	Static and turnover kinetic measurement of protein biomarkers involved in triglyceride metabolism including apoB48 and apoA5 by LC/MS/MS 2014 ·Journal of Lipid Research ·Yi Pan, Haihong Zhou, Ablatt Mahsut, Rory J. Rohm, (unknown), (unknown), Ying Chen, José Castro‐Perez, Michael E. Lassman, David G. McLaren, James Conway, Kristian K. Jensen, Tiffany Thomas, Gissette Reyes‐Soffer, Henry N. Ginsberg, David E. Gutstein, Michele A. Cleary, Stephen F. Previs, Thomas P. Roddy	17
10	Measuring H₂¹⁸O Tracer Incorporation on a QQQ-MS Platform Provides a Rapid, Transferable Screening Tool for Relative Protein Synthesis 2012 ·Journal of Proteome Research ·James Conway, Douglas G. Johns, Shengping Wang, Nykia D. Walker, Thomas McAvoy, Haihong Zhou, (unknown), Stephen F. Previs, Thomas P. Roddy, Brian K. Hubbard, Nathan A. Yates, Ronald C. Hendrickson	2
11	Dual Role of Peroxiredoxin I in Macrophage-derived Foam Cells 2006 ·Journal of Biological Chemistry ·James Conway, Michael Kinter	55
12	Proteomic and Transcriptomic Analyses of Macrophages with an Increased Resistance to Oxidized Low Density Lipoprotein (oxLDL)-induced Cytotoxicity Generated by Chronic Exposure to oxLDL 2005 ·Molecular & Cellular Proteomics ·James Conway, Michael Kinter	28
13	Removal of non-transferrin-bound iron from blood with iron overload using a device with immobilized desferrioxamine. 1999 ·PubMed ·Clara M. Ambrus, (unknown), (unknown), Alfred Stadler, S Anthone, (unknown), Pedro A. deAlarcon, (unknown), James Conway, A O Vladutiu, Julian L. Ambrus	2
14	Preadmission anaesthesia consultation clinics 1993 ·Ambulatory Surgery ·James Conway	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact